Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).

@article{Bress2017PotentialDA,
  title={Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).},
  author={Adam P Bress and Holly Kramer and Rasha Khatib and Srinivasan Beddhu and Alfred K. Cheung and Rachel Hess and Vinod Kumar Bansal and Guichan Cao and Jerry Yee and Andrew E Moran and R Durazo-arvizu and Paul Muntner and Richard S. Cooper},
  journal={Circulation},
  year={2017},
  volume={135 17},
  pages={
          1617-1628
        }
}
BACKGROUND SPRINT (Systolic Blood Pressure Intervention Trial) demonstrated a 27% reduction in all-cause mortality with a systolic blood pressure (SBP) goal of <120 versus <140 mm Hg among US adults at high cardiovascular disease risk but without diabetes mellitus, stroke, or heart failure. To quantify the potential benefits and risks of SPRINT intensive goal implementation, we estimated the deaths prevented and excess serious adverse events incurred if the SPRINT intensive SBP treatment goal… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Similar Papers

Loading similar papers…